---
schema_version: "secwatch.filing_event.v1"
accession: "0001404644-25-000053"
form_type: "8-K"
ticker: "NGNE"
cik: "0001404644"
company_name: "Neurogene Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T10:29:32.699938+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Neurogene shareholders approve equity plan amendments, elect directors

## Summary
- Amendments to 2023 Equity Incentive Plan and ESPP approved; shares from prefunded warrants and convertible preferred counted in automatic share reserve increase.
- Elected Sarah B. Noonberg and Robert 'Keith' Woods as Class II directors until 2028; each received >10.3M votes for.
- Say-on-pay advisory vote passed with 7.72M for (68.7% of votes cast excluding broker non-votes).
- Ratified Deloitte & Touche as independent auditor for FY2025; 99.9% of votes cast in favor.
- Quorum of 11.48M shares (80.5% of voting power) present at the June 12, 2025 annual meeting.

## SEC filing metadata
- accession: 0001404644-25-000053
- form_type: 8-K
- ticker: NGNE
- cik: 0001404644
- company_name: Neurogene Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404644/000140464425000053/0001404644-25-000053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404644/000140464425000053/ngne-20250612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001404644-25-000053
- JSON: https://secwatch.observer/filing/0001404644-25-000053.json
- Plain text: https://secwatch.observer/filing/0001404644-25-000053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.